Home > Result Summaries: Compounds > H5N1 Pandemic Influenza Vaccine > Result Summary for 111756

Result Summary for 111756

Result Summary

Protocol ID:	111756
Clinical Study ID:	111756
Official Title:	Immunogenicity and safety of GSK Biologicals’ (pre-) pandemic influenza candidate vaccine GSK 1557484A.
Phase:	phase 2
Study Indications or Diseases:	Influenza
Generic Name:	H5N1 Pandemic Influenza Vaccine
Trade/Product Name:	Pandemrix
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Nagai H et al. (2010) A phase II, open-label, multicentre study to evaluate the immunogenicity and safety of an adjuvanted prepandemic (H5N1) influenza vaccine in healthy Japanese adults. BMC Infectious Diseases. 10:338.